Alondra Ruiz Gutiérrez

Dr. Alondra Ruiz Gutiérrez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Ruth Rodríguez MontañoRuth Rodríguez Montaño
Ruth Rodríguez Montaño
AGAlondra Ruiz Gutiérrez
Alondra Ruiz Gutiérrez
VRVianeth María del Carmen Martínez Rodríguez
Vianeth María del Carmen Martínez Rodríguez
JGJuan Ramón Gómez
Juan Ramón Gómez
JGJuan Manuel Guzman-Flores
Juan Manuel Guzman-Flores
CGCelia Guerrero
Celia Guerrero
Background: Periodontitis (P) is a chronic inflammatory disease characterized by the destruction of periodontium support tissue generated by different immuno-inflammatory mechanisms, including the RANK/RANKL/OPG and the IL-23/IL-17 axis. Methods: The study was performed with healthy subjects (HS) and patients with periodontitis. Plasma samples were obtained from peripheral blood and the gingival tissue (GT) during periodontal surgery. The ELISA technique was used to evaluate the levels of IL-23, IL-17A, IL-23R, and IL-17RA. Results: In the plasma, a significant decrease in IL-17A was observed in patients with periodontitis than HS. In the GT, IL-23, IL-17A, and IL-17RA levels were increased in periodontitis patients; on the contrary, IL-23R levels were decreased in periodontitis patients when compared with HS. Finally, several positive correlations were found: soluble IL-17RA (sIL-17RA) levels in plasma between the percentage of radiographic bone loss (RBL%), and IL-23 with IL-17A in gingival tissue. Conclusions: The detection of the IL-23/IL-17A axis in gingival tissue and plasma provides us with more information on the behavior of this axis in a localized way in the periodontal microenvironment, in contrast to the systemic levels evaluated according to the new classification of periodontitis.

1 January 2021 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
AGAlondra Ruiz Gutiérrez
Alondra Ruiz Gutiérrez
Ruth Rodríguez MontañoRuth Rodríguez Montaño
Ruth Rodríguez Montaño
MPMaría Luisa Pita-López
María Luisa Pita-López
AZAna Lourdes Zamora-Perez
Ana Lourdes Zamora-Perez
CGCelia Guerrero
Celia Guerrero
Del Carmen Ruíz-Gutiérrez A, et al. J Periodontal Implant Sci. 2021 May;51:e17. https://doi.org/10.5051/jpis.2005380269

9 January 2025 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
NSNydia Yazmin Sanchez-Orozco
Nydia Yazmin Sanchez-Orozco
BRBob T. Rosier
Bob T. Rosier
AGAlondra Ruiz Gutiérrez
Alondra Ruiz Gutiérrez
FMFabiola Marquez-Sandoval
Fabiola Marquez-Sandoval
AAAlejandro Artacho
Alejandro Artacho
Alex MiraAlex Mira
Alex Mira
We have previously demonstrated that subgingival levels of nitrate-reducing bacteria, as well as the in vitro salivary nitrate reduction capacity (NRC), were diminished in periodontitis patients, increasing after periodontal treatment. However, it remains unclear if an impaired NRC in periodontitis can affect systemic health. To determine this, the effect of nitrate-rich beetroot juice (BRJ) on blood pressure was determined in 15 periodontitis patients before and 70 days after periodontal treatment (i.e., professional mechanical plaque removal, oral hygiene instruction, and subgingival instrumentation), as well as in a healthy control group of 15 individuals. Additionally, subgingival and tongue samples were taken to analyse the bacterial composition with Illumina sequencing of the 16S rRNA gene. In healthy individuals, the systolic and diastolic blood pressure (SBP and DPB) decreased significantly (both P < 0.01) 90 min after BRJ intake, but not in periodontitis patients. However, after periodontal treatment, this blood pressure-lowering effect was recovered (P < 0.05 for SBP; P < 0.01 for DBP). Lower levels of salivary nitrate after identical doses of BRJ intake indicated a potentially higher NRC in healthy individuals (P < 0.05). Periodontitis-associated bacteria decreased in tongue and subgingival samples after periodontal treatment (P < 0.01). In contrast, nitrate-reducing bacteria were associated with health in both habitats, but increased only in subgingival plaque after periodontal treatment (P < 0.001). This is the first study showing that periodontitis could limit the blood-pressure lowering effects of nitrate reduction by the oral microbiota. We propose that an impaired NRC represents a potential link between periodontitis and systemic conditions, which should be confirmed in future randomized controlled trials. Future work should also aim to determine if nitrate prebiotic supplementation and/or tongue cleaning could improve the treatment of periodontitis and its associated comorbidities.

6 December 2022 in World Journal of Clinical Cases
Verified
Journal Article
Open access
GRGiovanna Victory Rodríguez
Giovanna Victory Rodríguez
AGAlondra Ruiz Gutiérrez
Alondra Ruiz Gutiérrez
JSJuan Ramón Gómez Sandoval
Juan Ramón Gómez Sandoval
Sarah Monserrat LomeliSarah Monserrat Lomeli
Sarah Monserrat Lomeli
Cyclosporine is an immunosuppressive agent used effectively for treatment of a rare haematological disorder known as medullary aplasia. This drug prevents several side effects, including gingival enlargement (GE) which compromises aesthetics, phonetics and chewing, and also predisposes patients to periodontitis. This clinical case reports a 41-year-old woman who presented with cyclosporine-induced GE with underlying periodontitis and medullary aplasia. The man agement of the disease was approached through multidisciplinary strategy which allowed for accurate diagnosis and a strategic treatment based on the systemic condition and severity of oral pathology. The diagnosis was confirmed through histopathological analysis. The treatment was carried out in phases: Initial (oral hygiene motivation, mechanical supragingival plaque control, and non-surgical therapy); systemic treatment, corrective treatment, and maintenance. Multidisciplinary management of cyclosporine-induced GE and medullary aplasia allows for correct diagnosis and effective treatment of this pathological expression through a phased therapeutic approach.

16 July 2025 in World Journal of Clinical Cases
Verified
Journal Article
Open access
PMPatricia A Montiel-López
Patricia A Montiel-López
JGJuan C García-Nuñez
Juan C García-Nuñez
MMMari L Muro-Jiménez
Mari L Muro-Jiménez
ASAlma A Soto-Chávez
Alma A Soto-Chávez
VMVianeth M Martínez-Rodríguez
Vianeth M Martínez-Rodríguez
AGAlondra Ruiz Gutiérrez
Alondra Ruiz Gutiérrez
The generation of intrabony defects due to the iatrogenic use of elastic bands is an undesirable situation that can result in persistent gingival inflammation with subsequent bone degradation, thus ultimately leading to tooth loss. This clinical case involved a 27-year-old male patient who complained of persis tent inflammation and bleeding in the upper anterior region of the gums, despite having undergone dental cleaning for at least 4 years. The dental and medical history indicated the use of removable orthodontic appliances for 8 years, after which braces were placed for 2 years. The intraoral evaluation revealed inflammation and localized suppuration in teeth 11 and 12. Measurements of 2-7 mm for probing depth and 1-5 mm for clinical attachment loss were detected, and com bined bone loss was observed via radiographs. Based on the clinical and radiogra phic findings, localized stage III, grade C periodontitis was diagnosed. During subgingival debridement, two elastic bands emerged around the involved teeth. The bone defects persisted; therefore, they were surgically addressed using a papilla preservation flap and guided tissue regeneration (GTR). The use of elastic bands of various sizes and elasticities is often essential in multiple orthodontic treatments. However, it is crucial to perform a thorough check-up for each patient during treatment and at the end of treatment to remove any remaining residue of resin, metal bands, or orthodontic bands. Additionally, it is imperative to inform the patients of the importance of attending their follow-up appointments. The use of elastic bands in orthodontics requires special care; moreover, GTR is a management option for intrabony defects associated with the iatrogenic use of bands.

10 February 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Ruth Rodríguez MontañoRuth Rodríguez Montaño
Ruth Rodríguez Montaño
YPYesenia Isahy Ponce-Gómez
Yesenia Isahy Ponce-Gómez
Sarah Monserrat LomeliSarah Monserrat Lomeli
Sarah Monserrat Lomeli
SSSonia Sifuentes-Franco
Sonia Sifuentes-Franco
AGAlondra Ruiz Gutiérrez
Alondra Ruiz Gutiérrez
JGJuan Ramón Gómez
Juan Ramón Gómez
Background: Patients usually present pain due to the release of different inflammatory mediators such as prostaglandin E2 and RANK-L. Analgesics such as acetaminophen and ketorolac can inhibit RANK-L expression and this can affect orthodontic treatment by decreasing bone remodeling and slowing orthodontic dental movement. Several studies have reported a decrease in dental movement after administering some non-steroidal anti-inflammatory drugs. Proposal: The objective was to evaluate the RANK-L levels and a possible modulation by administering acetaminophen and ketorolac in patients starting orthodontic treatment. Methodology: A double-blind, randomized clinical trial was carried out with 24 subjects divided into three study groups: calcined magnesia as a placebo, acetaminophen, and ketorolac. Gingival crevicular fluid was obtained at four time points: before pharmacological intervention, at 24 h, at 48 h, and on the 5th day. RANK-L concentrations were evaluated through ELISA analysis. Also, interproximal space generated by the elastic separator at the end of the study was recorded in the different study groups using the visual analog scale. Results: An increase in RANK-L at 24 h was observed in the placebo group compared to the ketorolac and acetaminophen groups. However, no significant differences were observed in the interproximal space at day 5 in the three study groups. Conclusion: Patients who do not take analgesics at the start of orthodontic treatment have higher levels of RANK-L. Therefore, the use of ketorolac or acetaminophen could decrease bone remodeling and interfere with orthodontic dental movement.